BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32464196)

  • 1. Mdm4 controls ureteric bud branching via regulation of p53 activity.
    Hilliard SA; Li Y; Dixon A; El-Dahr SS
    Mech Dev; 2020 Sep; 163():103616. PubMed ID: 32464196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching.
    Hilliard S; Aboudehen K; Yao X; El-Dahr SS
    Dev Biol; 2011 May; 353(2):354-66. PubMed ID: 21420949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prorenin receptor controls renal branching morphogenesis via Wnt/β-catenin signaling.
    Song R; Janssen A; Li Y; El-Dahr S; Yosypiv IV
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F407-F417. PubMed ID: 28031172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the prorenin receptor from the ureteric bud causes renal hypodysplasia.
    Song R; Preston G; Ichihara A; Yosypiv IV
    PLoS One; 2013; 8(5):e63835. PubMed ID: 23704941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud.
    Zhao H; Kegg H; Grady S; Truong HT; Robinson ML; Baum M; Bates CM
    Dev Biol; 2004 Dec; 276(2):403-15. PubMed ID: 15581874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II AT2 receptor regulates ureteric bud morphogenesis.
    Song R; Spera M; Garrett C; El-Dahr SS; Yosypiv IV
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F807-17. PubMed ID: 20032120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm2 is required for maintenance of the nephrogenic niche.
    Hilliard SA; Yao X; El-Dahr SS
    Dev Biol; 2014 Mar; 387(1):1-14. PubMed ID: 24440154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage specific requirement of Gfrα1 in the ureteric epithelium during kidney development.
    Keefe Davis T; Hoshi M; Jain S
    Mech Dev; 2013; 130(9-10):506-18. PubMed ID: 23542432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development.
    Majumdar A; Vainio S; Kispert A; McMahon J; McMahon AP
    Development; 2003 Jul; 130(14):3175-85. PubMed ID: 12783789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium.
    Chen S; Yao X; Li Y; Saifudeen Z; Bachvarov D; El-Dahr SS
    Development; 2015 Mar; 142(6):1180-92. PubMed ID: 25758227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development.
    Zhang Q; He X; Chen L; Zhang C; Gao X; Yang Z; Liu G
    J Pathol; 2012 Nov; 228(3):416-28. PubMed ID: 22821713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLI3 repressor controls nephron number via regulation of Wnt11 and Ret in ureteric tip cells.
    Cain JE; Islam E; Haxho F; Chen L; Bridgewater D; Nieuwenhuis E; Hui CC; Rosenblum ND
    PLoS One; 2009 Oct; 4(10):e7313. PubMed ID: 19809516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ret and Etv4 Promote Directed Movements of Progenitor Cells during Renal Branching Morphogenesis.
    Riccio P; Cebrian C; Zong H; Hippenmeyer S; Costantini F
    PLoS Biol; 2016 Feb; 14(2):e1002382. PubMed ID: 26894589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability.
    Pant V; Xiong S; Iwakuma T; Quintás-Cardama A; Lozano G
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11995-2000. PubMed ID: 21730132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.
    Xiong S; Van Pelt CS; Elizondo-Fraire AC; Liu G; Lozano G
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3226-31. PubMed ID: 16492743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis.
    Yosypiv IV
    Pediatr Nephrol; 2009 Jun; 24(6):1113-20. PubMed ID: 18958502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4.
    Grier JD; Xiong S; Elizondo-Fraire AC; Parant JM; Lozano G
    Mol Cell Biol; 2006 Jan; 26(1):192-8. PubMed ID: 16354690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASH2L Controls Ureteric Bud Morphogenesis through the Regulation of RET/GFRA1 Signaling Activity in a Mouse Model.
    Zhao Z; Dai X; Jiang G; Lin F
    J Am Soc Nephrol; 2023 Jun; 34(6):988-1002. PubMed ID: 36758123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse models of Mdm2 and Mdm4 and their clinical implications.
    Xiong S
    Chin J Cancer; 2013 Jul; 32(7):371-5. PubMed ID: 23327795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development.
    Steinman HA; Hoover KM; Keeler ML; Sands AT; Jones SN
    Oncogene; 2005 Nov; 24(53):7935-40. PubMed ID: 16027727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.